Skip to main content
NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.61%GBPCHF+0.52%AUDCHF+0.46%NZDCHF+0.45%GBPTRY+0.41%USDCAD-0.39%EURCAD-0.35%GBPHKD+0.32%CADJPY+0.31%AUDSGD+0.31%GBPUSD+0.30%NZDSGD+0.30%GBPMXN-0.28%USDTRY+0.27%NZDUSD+0.27%CHFJPY-0.27%AUDUSD+0.26%USDNOK-0.26%EURCHF+0.25%EURGBP-0.23%NZDMXN+0.23%GBPJPY+0.22%USDZAR-0.21%USDCHF+0.20%GBPSGD+0.20%EURAUD-0.18%AUDJPY+0.18%NZDJPY+0.18%NOKJPY+0.17%EURNZD-0.17%EURNOK-0.16%USDILS+0.16%AUDDKK+0.16%CHFNOK-0.16%CHFSGD+0.16%NZDCAD-0.16%USDSEK-0.16%EURSGD+0.15%USDPLN-0.15%SGDJPY-0.14%AUDCAD-0.13%EURZAR-0.12%EURHKD+0.09%USDDKK-0.09%GBPZAR-0.08%GBPCAD-0.08%USDJPY-0.07%PLNJPY+0.07%EURSEK-0.07%EURCNH+0.06%CHFSEK-0.06%EURUSD+0.06%USDSGD+0.06%GBPAUD+0.06%EURPLN-0.06%USDCOP-0.04%GBPNZD+0.03%USDCNH-0.03%USDTHB+0.03%AUDNZD+0.02%USDMXN-0.01%EURJPY-0.01%EURCZK+0.01%USDHKD+0.01%AUDNOK0.00%EURDKK0.00%HG1+0.74%COTTON+0.71%S1+0.47%XNGUSD+0.32%W1-0.28%XAGUSD+0.26%GAGUSD+0.25%UKOIL-0.18%USOIL-0.16%XAUUSD+0.13%GAUUSD+0.13%XPTUSD+0.06%BTCUSD+2.39%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.57%DOGEUSD+14.12%XMRUSDT+5.80%LINKUSD+13.42%XLMUSD+0.27%BCHUSDT+5.89%UNIUSD+7.49%LTCUSD+9.66%SUIUSD+3.37%HBARUSDT+0.35%TONUSD+26.15%TAOUSDT+3.90%AAVEUSD+3.58%DOTUSDT-0.20%ICPUSDT+0.78%ONDOUSDT+0.36%WLDUSDT-0.02%ARBUSDT+6.66%JUPUSDT+0.62%ATOMUSDT+1.90%INJUSDT+13.30%STXUSDT+6.52%FETUSDT+2.74%TIAUSDT+9.19%PYTHUSDT-0.74%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+18.94%GRTUSDT+4.09%IOTAUSDT+0.88%WIFUSDT+2.70%AXSUSDT-1.83%POLUSDT+2.78%FARTCOINUSDT+0.63%EOSUSDT+2.70%DYDXUSDT+3.44%GALAUSDT-1.87%ORDIUSDT-0.09%RONINUSDT-3.42%NOTUSDT+1.21%NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.61%GBPCHF+0.52%AUDCHF+0.46%NZDCHF+0.45%GBPTRY+0.41%USDCAD-0.39%EURCAD-0.35%GBPHKD+0.32%CADJPY+0.31%AUDSGD+0.31%GBPUSD+0.30%NZDSGD+0.30%GBPMXN-0.28%USDTRY+0.27%NZDUSD+0.27%CHFJPY-0.27%AUDUSD+0.26%USDNOK-0.26%EURCHF+0.25%EURGBP-0.23%NZDMXN+0.23%GBPJPY+0.22%USDZAR-0.21%USDCHF+0.20%GBPSGD+0.20%EURAUD-0.18%AUDJPY+0.18%NZDJPY+0.18%NOKJPY+0.17%EURNZD-0.17%EURNOK-0.16%USDILS+0.16%AUDDKK+0.16%CHFNOK-0.16%CHFSGD+0.16%NZDCAD-0.16%USDSEK-0.16%EURSGD+0.15%USDPLN-0.15%SGDJPY-0.14%AUDCAD-0.13%EURZAR-0.12%EURHKD+0.09%USDDKK-0.09%GBPZAR-0.08%GBPCAD-0.08%USDJPY-0.07%PLNJPY+0.07%EURSEK-0.07%EURCNH+0.06%CHFSEK-0.06%EURUSD+0.06%USDSGD+0.06%GBPAUD+0.06%EURPLN-0.06%USDCOP-0.04%GBPNZD+0.03%USDCNH-0.03%USDTHB+0.03%AUDNZD+0.02%USDMXN-0.01%EURJPY-0.01%EURCZK+0.01%USDHKD+0.01%AUDNOK0.00%EURDKK0.00%HG1+0.74%COTTON+0.71%S1+0.47%XNGUSD+0.32%W1-0.28%XAGUSD+0.26%GAGUSD+0.25%UKOIL-0.18%USOIL-0.16%XAUUSD+0.13%GAUUSD+0.13%XPTUSD+0.06%BTCUSD+2.39%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.57%DOGEUSD+14.12%XMRUSDT+5.80%LINKUSD+13.42%XLMUSD+0.27%BCHUSDT+5.89%UNIUSD+7.49%LTCUSD+9.66%SUIUSD+3.37%HBARUSDT+0.35%TONUSD+26.15%TAOUSDT+3.90%AAVEUSD+3.58%DOTUSDT-0.20%ICPUSDT+0.78%ONDOUSDT+0.36%WLDUSDT-0.02%ARBUSDT+6.66%JUPUSDT+0.62%ATOMUSDT+1.90%INJUSDT+13.30%STXUSDT+6.52%FETUSDT+2.74%TIAUSDT+9.19%PYTHUSDT-0.74%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+18.94%GRTUSDT+4.09%IOTAUSDT+0.88%WIFUSDT+2.70%AXSUSDT-1.83%POLUSDT+2.78%FARTCOINUSDT+0.63%EOSUSDT+2.70%DYDXUSDT+3.44%GALAUSDT-1.87%ORDIUSDT-0.09%RONINUSDT-3.42%NOTUSDT+1.21%
AL

Abbott Laboratories (ABT)

NYSE • Healthcare

$102.61
+$0.79 (+0.8%)
Market closed

October 13, 2026 at 20:00 UTC

Open$102.59
Day Range$100.63 - $103.44
Avg. Volume (3M)9.4M
Market Cap$177.6B
P/E Ratio33.0
52 Week Range
$81.97$132.03
Next EarningsIn 7 daysOct 21, 2026

Interactive Chart

05:04:19 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$12.5B100%
Gross Profitminus cost of goods$7.3B58%
Operating Incomeminus R&D and overhead$1.7B14%
Net Incomeminus taxes and the rest$928M7%

In plain terms: out of every $100 in revenue, Abbott Laboratories keeps $7 as net profit.

Fundamentals & Financials

Revenue (TTM)
$46.5B
Net Income (TTM)
$5.4B
EPS (TTM)
$3.11
ROA (TTM)
4.97%
Current Ratio
1.38
Dividend Yield
0.7%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

0.0%Q1 2026$1.5
+0.9%Q2 2026$1.15
+2.3%Q3 2026$1.31
Next

Oct 21

in 7 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +2.3%

Abbott Laboratories' adjusted EPS topped consensus while revenue came in line in the second fiscal quarter of 2026, reported July 16, as revenue rose 13% to about $12.6 billion and gross margin held near 58% while operating margin was around 14%. Adjusted EPS of $1.31 topped the $1.28 estimate, +2.3%, and revenue of $12.593 billion was in line with the $12.519 billion consensus, +0.6%; net income fell 47.8% to about $928 million from $1.779 billion a year ago, even as adjusted EPS rose 4% from $1.26. Operating cash flow was $2.488 billion, the company repurchased about $1.0 billion of stock and paid about $1.1 billion in dividends. Next-period consensus calls for EPS of $1.42 on revenue of $12.991 billion.

Next report — what to expect

Abbott Laboratories (ABT) is scheduled to report earnings on October 21, 2026. Wall Street’s next-period consensus calls for EPS of $1.43 on revenue of $12.99 billion. As trailing context, revenue grew +13.0% year over year last quarter. Abbott has beaten EPS in 4 of 8 most recent quarters.

View full earnings history

About Abbott Laboratories

Abbott Laboratories (NYSE: ABT) is a healthcare company centered on medical devices, diagnostics, nutrition, and branded generic medications sold through worldwide distribution, with operations that reach global markets. Across these businesses, Abbott generated $44.3 billion of revenue in FY2025, spanning products used in testing, chronic disease management, and everyday nutritional care.

Name
Abbott Laboratories
CEO
Robert Ford
Website
www.abbott.com
Industry
Healthcare
Year Founded
1888
Employees
115,000

Today's Snapshot

AI-generated

ABT closed 0.8% above yesterday's close, outperforming a weaker sector. Abbott Laboratories drew a $120 price target from Barclays, a bank. Earnings are due from ABT on 21 October.

Trading Volume

Above 10d avg 9.5M

9.8M

vs S&P 500 Today

Outperforming Market

+0.85%

Updated: October 13, 2026 at 20:30 UTC

ABT Headlines

Abbott settles U.S. infant formula claims

September 14, 2026

2 min read

Abbott sets $670 million in infant formula deals

August 20, 2026

3 min read

Abbott hit with $53 million infant formula verdict

April 10, 2026

4 min read

Citi Resets Life Sciences And MedTech Views

March 11, 2026

5 min read
View All News

Technical Indicators

3 Buy3 Neutral2 Sell
ABT's technicals favor a buy posture supported by a moderate trend and constructive short-term structure. ADX indicates a firming trend while the stock trades at or just above short- and medium-term averages even though the 200-day level remains slightly higher, signaling partial longer-term resistance. Momentum is mildly positive and RSI is neutral, suggesting steady internals without overheating; volatility is relatively subdued and on-balance volume points to underlying buying. The classic pivot lies just below the market as support. Technical takeaway: Buy — short-term trend support with limited volatility.
All signals
  • EMA (5 indicators)$100.36 - $107.23
    Buy
  • RSI (14)52.37
    Neutral
  • Stochastic %K (14, 3, 3)67.80
    Neutral
  • MACD Level (12, 26)-1.37
    Neutral

Peers & Related Assets

JNJJohnson & Johnson
$248.61-5.7%
TMOThermo Fisher Scientific Inc.
$663.04+0.1%
DHRDanaher Corporation
$222.84+0.7%
MDTMedtronic Plc
$93.01+1.2%
SYKStryker Corporation
$282.55-0.0%
BSXBoston Scientific Corporation
$43.31-1.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.